CIBC Private Wealth Group LLC
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1298088
ATLANTA, GA
Position in ALNY
as of Dec 31, 2025
· filed Feb 12, 2026
Position Value
$79,699,001
-$17,982,127 QoQ
Shares Held
200,425
-6.4% QoQ
Ownership
0.151%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
20 quarters on record
Voting authority
Sole 99.67918173880503.ToString("F0")%
Shared 0.ToString("F0")%
None 0.3208182611949607.ToString("F0")%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Dec 31, 2025CIBC Private Wealth Group LLC holds $101,906,850 across 130 Biotechnology names. ALNY ranks #1 (78.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
200,425 | $79,699,001 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,087 | $3,212,962 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
15,684 | $2,864,525 | |
| 4 | LXRX |
Lexicon Pharmaceuticals, Inc.
|
1,950,000 | $2,242,500 | |
| 5 | ASND |
Ascendis Pharma A/S
|
9,382 | $2,000,617 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,943 | $1,499,743 | |
| 7 | PGEN |
Precigen, Inc.
|
274,712 | $1,148,296 | |
| 8 | MRVI |
Maravai Lifesciences Holdings, Inc.
|
279,224 | $907,478 |
All Filings in ALNY
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $79,699,001 | 200,425 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $97,681,128 | 214,213 | Shares | Defined | 2025-11-24 | |
| 2025-06-30 | $71,194,903 | 218,329 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $55,492,079 | 205,511 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $47,854,523 | 203,368 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $57,339,904 | 208,486 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $50,153,013 | 206,391 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $26,041,513 | 174,249 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $33,248,108 | 173,701 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $30,838,423 | 174,130 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $33,146,809 | 174,512 | Shares | Other | 2023-11-21 | |
| 2023-03-31 | $24,234,913 | 120,981 | Shares | Other | 2023-11-21 | |
| 2022-12-31 | $28,961,454 | 121,866 | Shares | Other | 2023-06-01 | |
| 2022-09-30 | $23,900,705 | 119,408 | Shares | Other | 2022-11-15 | |
| 2022-06-30 | $16,953,895 | 116,242 | Shares | Defined | 2022-08-03 | |
| 2022-03-31 | $19,640,030 | 120,277 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $20,053,173 | 118,252 | Shares | Defined | 2022-04-04 | |
| 2021-09-30 | $22,495,767 | 119,145 | Shares | Other | 2021-11-12 | |
| 2021-06-30 | $20,124,735 | 118,716 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $17,826,648 | 126,260 | Shares | Defined | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||